Trials / Completed
CompletedNCT00125294
Sublingual Methadone for the Management of Cancer Breakthrough Pain
Evaluation of a Dose Titration Protocol for Sublingual Methadone Hydrochloride for the Management of Cancer-related Breakthrough Pain
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- AHS Cancer Control Alberta · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A dose titration protocol for sublingual methadone hydrochloride for the management of cancer-related breakthrough pain to find the optimal dose.
Detailed description
This is a dose titration protocol for sublingual methadone hydrochloride for the management of cancer-related breakthrough pain to find the optimal dose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methadone |
Timeline
- Start date
- 2003-09-01
- Primary completion
- 2006-06-01
- Completion
- 2007-01-01
- First posted
- 2005-08-01
- Last updated
- 2017-09-25
Source: ClinicalTrials.gov record NCT00125294. Inclusion in this directory is not an endorsement.